Cogentix Medical (CGNT) Misses Q4 EPS by 6c

Cogentix Medical (NASDAQ: CGNT) reported Q4 EPS of $0.16, $0.06 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $125 million versus the consensus estimate of $129.55 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Evolution Petroleum closes $16M Midland Basin royalty acquisition
• ScanSource (SCSC) Tops Q4 EPS by 32c